Navigation Links
Misperceptions About Smoking Cessation Aids May Hinder Smokers From Using Effective Treatment for Quitting
Date:2/29/2008

Data presented at national conference provides important insight into how

underutilization of treatments is jeopardizing quit attempts

PORTLAND, Ore., Feb. 29 /PRNewswire-FirstCall/ -- Leading researchers in the field of smoking cessation are gathering at the annual meeting of the Society for Research on Nicotine and Tobacco (SRNT) to present the latest research on smoking cessation, including a new study revealing smokers' misperceptions about cessation treatments.

The study's findings indicate smokers dramatically underestimate the safety and efficacy of nicotine replacement therapy (NRT) products for quitting smoking, which may lead to less use of proven smoking cessation therapy that has been proven to double a smoker's chances of quitting.(1,2) Presentation findings were based on a study of 900 men and women adult smokers in the U.S.(1)

Seventy-six percent of smokers wrongly believe or do not know whether NRT is more addictive than cigarettes.(1) Additionally, 68 percent of smokers wrongly answered or do not know that NRT products are as dangerous as cigarettes.(1) Less than three percent of respondents answered all questions about treatment correctly, demonstrating the enormous need for further education.(1,3)

The good news is that even if smokers held these misperceptions, about half of them stated they would be more likely to consider NRT if they were shown scientific evidence that proves its safety.(1)

"Cessation treatments like nicotine replacement therapy have been proven to greatly increase the chances of successfully quitting," said Dr. Donna Vallone, Senior Vice President, Research and Evaluation American Legacy Foundation. "The research findings only reinforce the point that treatments for cessation are underutilized thereby jeopardizing successful attempts at quitting. More needs to be done to educate smokers."

The majority of smokers try to quit "cold turkey," yet only 3-5 percent of smokers wh
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
2. Montana State University lab gives early warnings about biological invaders
3. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
4. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
5. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
6. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
7. Stevens researchers provide new information about mass spectrometry
8. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating
9. Evotec Starts Phase II in Smoking Cessation with EVT 302
10. Laser Therapy Gives Smokers Hope for Successful New Years Resolution
11. Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 MGB Biopharma ... resistance problem  MGB Biopharma, a biopharmaceutical ... to address the major global problem of antibiotic ... stable intravenous (IV) formulation of MGB-BP-3, designed for the ... The intravenous formulation of MGB-BP-3 is ...
(Date:6/1/2015)... New York, NY (PRWEB) June 02, 2015 ... informative views on health care, Jack Uldrich has ... pharmaceutical firm in New York today. He will ... , Uldrich has delivered presentations to ... American Academies of Audiology and Neurology, Alcetel-Lucent/Verizon Forum ...
(Date:6/1/2015)... South Korea , June 1, 2015 /PRNewswire/ ... Biotherapeutics Inc. (GCBT) kicked off construction today on its ... Technoparc,s Saint-Laurent Campus. The CA$315 million project represents one ... Canada in the biopharmaceutical industry, giving ... (IVIG) and albumin manufacturing plant in Canada ...
(Date:6/1/2015)... -- About Bio-alcohols Bio-alcohols are organic ... Bio-alcohols are primarily used in the transportation sector. For ... gasoline in cars. Technavio,s analysts forecast the global bio-alcohols ... over the period 2014-2019. Covered in ... into five: transportation, infrastructure, medical, and others. Technavio,s report, ...
Breaking Biology Technology:MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3Global Bio-alcohols Market 2015-2019 2
... Inc. (Nasdaq: GHDX ) today announced that ... will present at the JMP,Securities Healthcare Focus Conference ... 10:00 a.m. ET., To access the live ... Investor Relations section of Genomic Health,s,website at ...
... Sept. 30 Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTA: ... Milan,Italy on October 3, 2008. The investor day will ... and regulatory milestones,for the Company. Additionally, Alessandro Gianni, M.D., ... the University of Milan,who has authored over 300 publications ...
... (Nasdaq: SGMO ) announced today that Edward Lanphier,Sangamo,s ... progress of,Sangamo,s ZFP Therapeutic development programs and an overview ... Monday, October 6, 2008,at the 2008 JMP Securities Healthcare ... 7, 2008 at the William Blair Small Cap Conference.,Both ...
Cached Biology Technology:Cell Therapeutics Provides Details on Investor & Media Day to be Held in Milan, Italy on Friday, October 3, 2008 2Sangamo BioSciences to Present at Two Upcoming Investor Conferences 2
(Date:5/10/2015)... 2015 Fingerprint Cards (FPC) has received ... from the distributor World Peace Industrial Group (WPI), part of ... Asia . Deliveries are planned to take place ... smartphone manufacturers in China . The order ... guidance of + 1 000 MSEK for 2015.   ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, reminds investors and media that  Mr. David Tunnell ... SECURE CONNEXIONS AMERICA 2015, held in Washington DC ... conference is organized into a series of nine session tracks. ... Fraud: Where is the Trust in Cyberspace? and will ...
(Date:4/21/2015)... , April 21, 2015 ... evolving government policies are boosting access control systems market ... According to a recently published report by TechSci ... 2020 ", the access control systems market in ... USD1.2 billion by 2020.The access control systems market in ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
... at the University of Virginia have discovered a new ... storage and transportation of energy much more efficient ... Bellave S. Shivaram and Adam B. Phillips, the U.Va. ... finding at 8 p.m., Monday, Nov. 12, at the ...
... study led by researchers at the University of Southern California ... distinct changes in the density of nucleosomes within the cells. ... the journal Cancer Cell, will enable researchers to explore new ... to novel treatments for human cancers, says study lead author ...
... On September 10, 2007, ConsumerLab.com issued ... contain label amounts of folic acid. One of these ... part of U. S. Pharmacopeias (USP) Dietary Supplement Verification ... to the report, USP studied the verified product to ...
Cached Biology News:Scientists discover record-breaking hydrogen storage materials for use in fuel cells 2Market testing of dietary supplements and drugs underscores value of USP's public health programs 2
The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
2,4-Dinitrophenyl hapten is conjugated to Keyhole Limpet (KLH) protein through lysine....
Alexa Fluor 350/488/594 Filter Set (Semrock Brightline) *mounted* *Zeiss Axio AF...
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
Biology Products: